Lv3
308 积分 2022-12-10 加入
Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection?
1个月前
已完结
The impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced HBV-specific humoral and cellular immune responses
1个月前
已完结
Design and biochemical evaluation of 2-cyclopropyl-thioureidobenzamide (CP-TBA) derivatives as potent HBV capsid assembly modulators targeting a novel binding site
1个月前
已完结
A nucleosome switch primes hepatitis B virus infection
2个月前
已完结
Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients
3个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
6个月前
已关闭
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
7个月前
已完结
Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
7个月前
已完结
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
8个月前
已完结
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
1年前
已完结
皖公网安备34019202002308
